Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,017 across all filing types
Latest filing 2012-09-18 Regulatory Filings
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2012
Regulatory Filings
2012-09-18 English
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document is a correspondence letter responding to SEC comments regarding the company's previously filed Form 10-Q for the quarter ended June 30, 2012. It includes a statement from management about the effectiveness of disclosure controls and procedures, which is a typical response to SEC review comments. The document does not contain the actual financial statements or substantive financial data from the 10-Q report itself, but rather an amendment and explanation related to the filing. The length is short (2129 characters), and it is primarily a regulatory response letter. According to the rules, such correspondence and certifications related to filings should be classified as Regulatory Filings (RNS), not as the report itself (IR).
2012-09-17 English
10-Q/A
Interim / Quarterly Report Q1 2013
2012-09-17 English
Regulatory Filings 2012
Regulatory Filings
2012-09-05 English
Regulatory Filings 2012
Regulatory Filings Classification · 90% confidence The document text appears to be an encoded or binary attachment (e.g., a uuencoded PDF file) rather than readable text. There are no clear indications of report titles, fiscal periods, regulatory bodies, or specific financial data. The length is about 15,000 characters, but the content is not human-readable and does not contain substantive financial statements or analysis. Given the lack of readable content and the nature of the text, this is likely an attachment or supplementary file rather than a full report or announcement. According to the rules, if the document does not fit neatly into any specific category and lacks readable content, it should be classified as a Regulatory Filing (RNS).
2012-09-05 English
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document is a letter responding to SEC comments on a previously filed Form 10-K for the fiscal year ended March 31, 2012. It addresses specific SEC requests and clarifications regarding public float calculation, disclosure controls and procedures, and pro forma financial statements. The letter includes acknowledgments and is signed by the CFO. It does not contain the full 10-K report itself but is a correspondence related to the 10-K filing. Given the nature of the document as a response to SEC comments on a 10-K filing, it fits best under Regulatory Filings (RNS) as it is a regulatory communication rather than the actual annual report or audit report.
2012-08-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.